US-based digital health company Owlet has launched its medically certified wearable baby monitor, Dream Sock, in South Africa.
The Dream Sock, classified as a Class C Medical Device and CE mark approved, monitors a baby’s pulse rate, oxygen levels, and sleep patterns.
It sends the real-time data to the Owlet Dream App and a base station, alerting parents if readings fall outside preset zones.
Designed for babies aged zero to 18 months, the advanced monitoring device allows parents to track infants’ vital signs and receive instant health notifications.
The product provides access to past health and sleep records and is available on both iOS and Android platforms.
Its launch in South Africa extends the digital health company’s global presence beyond North America and Europe.
Owlet president Jonathan Harris said: “With the launch of Dream Sock as a pediatric medical device in South Africa, we’re taking another important step toward our vision of reaching every family with Owlet’s life-changing technology.
“As we expand into more countries, we’re making hospital-grade monitoring accessible to more parents than ever before, empowering them with the real-time insights they need to care for their little ones.”
Owlet’s Dream Sock, discreetly worn under sleepwear, includes predictive sleep technology, which advises parents on optimal nap and bedtime windows.
The device meets medical device standards worldwide and integrates with the Owlet Cam 2, offering caregivers HD video, audio, and motion alerts.
In South Africa, the Dream Sock is NAPPI coded, enabling eligible buyers to seek reimbursement through medical aid, said Owlet.
